| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10953737 | Journal of Molecular and Cellular Cardiology | 2015 | 9 Pages |
Abstract
This review introduces the different ncRNA types and focuses at the ncRNA roles in diabetes vascular complications. Furthermore, we discuss the potential value of ncRNAs as clinical biomarkers, and we examine the possibilities for therapeutic intervention targeting ncRNs in diabetes. This article is part of a Special Issue titled: Non-coding RNAs.
Keywords
(NC)(NT)(CAD)tumour growth factorprecursor miRNA(DM)(TF)long ncRNA(SNP)primary miRNAs(IL-6)(AS)3′-untranslated regionnoncoding RNAlong noncoding RNAsArgonauteAntisenseAngiotensin IIinsulin-like growth factor-1critical limb ischemiainterleukin 6coronary artery diseaseDiabetesExtracellular vesiclessilencing RNAGestational diabetesDiabetes mellitustype 1 diabetes mellitusType 2 diabetes mellitusMicroparticlesmicroRNAsHuman umbilical vein endothelial cellmononuclear cellEndothelial cellVascular smooth muscle cellsbone marrow-derived cellsEndothelial progenitor cellsVascular cellsTranscription factorsNoncodingVascular endothelial growth factor Afibroblast growth factorGenome-wide association studybone marrow5′-untranslated regionMicroRNABiomarkersNucleotidepolymerase IISingle nucleotide polymorphismsadvanced glycation end productcirculating angiogenic cellshigh glucoseIGF receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Cristina Beltrami, Timothy G. Angelini, Costanza Emanueli,